attr

Documents about attr

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy#884032ClinicalTrials.gov
• Thailand ATTR-CM Registry#1057281ClinicalTrials.gov
• DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting#1138776ClinicalTrials.gov
• Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM#992435ClinicalTrials.gov
• Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)#1212845ClinicalTrials.gov
• APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)#1408892ClinicalTrials.gov
• NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis#842813ClinicalTrials.gov
• Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor#995265ClinicalTrials.gov
• To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)#1372556ClinicalTrials.gov
• A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy#895483ClinicalTrials.gov
• hATTR Polyneuropathy in Russia#905890ClinicalTrials.gov
• Edge-to-edge Mitral Valve Repair in ATTR-CM#993937ClinicalTrials.gov
• Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR#1139716ClinicalTrials.gov
• ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)#1338209ClinicalTrials.gov
• Vyndaqel Capsules Special Investigation (ATTR-CM)#865431ClinicalTrials.gov
• Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)#1126029ClinicalTrials.gov
• Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology#1172332ClinicalTrials.gov
• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)#1384156ClinicalTrials.gov
• SAML V2.0 Attribute Predicate Profile Version 1.0 (2011-11-29)#600838OASIS Open
• SAML V2.0 Metadata Extension for Entity Attributes Version 1.0 (2009-08-04)#600852OASIS Open
• ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy#1183228ClinicalTrials.gov
• Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations#1398419ClinicalTrials.gov
• SAML V2.0 Subject Identifier Attributes Profile Version 1.0 (2019-01-17)#600860OASIS Open
• ATTR-CM: A Multi-country, Non-interventional Disease Registry#405228ClinicalTrials.gov
• The application/pkix-attr-cert Media Type for Attribute Certificates#501250IETF RFCs
• ATTR Expanded Access Program (EAP) by Ionis#908008ClinicalTrials.gov
• XACML v3.0 Dynamic Attribute Authority Version 1.0 – Committee Specification 01 (2022-01-25)#601000OASIS Open
• Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis#1279835ClinicalTrials.gov
• SAML V2.0 Protocol Extension for Requesting Attributes per Request Version 1.0 (2017-08-24)#600858OASIS Open
• Targeted Testing for ATTR Among Aortic Stenosis Patients-Pilot#1232052ClinicalTrials.gov
• International Cardiac Amyloidosis Registry#1124534ClinicalTrials.gov
• Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy#1260971ClinicalTrials.gov
• US Benchmarking Clinical Study#917495ClinicalTrials.gov
• Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis#828031ClinicalTrials.gov
• An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy#848382ClinicalTrials.gov
• Clinical Study of ATTR-CM#1279589ClinicalTrials.gov
• The Italian Transthyretin Amyloidosis Web-Network#1281548ClinicalTrials.gov
• The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients#1382746ClinicalTrials.gov
• ATTR Amyloidosis in Elderly Patients With Aortic Stenosis#1421067ClinicalTrials.gov
• Comparative Effectiveness of TTR Stabilizers for the Treatment of ATTR-CM Using Real-World Evidence#223956bioRxiv / medRxiv
• A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours#1087904ClinicalTrials.gov
• Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis#1197069ClinicalTrials.gov
• Study for Vignette in Fontenelle's (attr.) "Les Amours de Mirtil", Canto V#673669Art Institute of Chicago
• Study for Vignette in Fontenelle's (attr.) "Les Amours de Mirtil", Canto II#673672Art Institute of Chicago
• Study for Vignette in Fontanelle's (attr.) "Les Amours de Mirtil", Canto I#673673Art Institute of Chicago
• Study for Vignette in Fontenelle's (attr.) "Les Amours de Mirtil", Canto IV#673674Art Institute of Chicago
• Study for Vignette in Fontenelle's (attr.) "Les Amours de Mirtil", Canto VI#673675Art Institute of Chicago
• Study for Vignette in Fontenelle's (attr.) "Les Amours de Mirtil", Canto III#673676Art Institute of Chicago
• A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM#859144ClinicalTrials.gov
• Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis#1395274ClinicalTrials.gov